Skip to main content

The price premium of generic to brand-names and pharmaceutical price index

Buy Article:

$53.17 plus tax (Refund Policy)

Abstract:

The price premium of generic pharmaceuticals to brand-names is examined under different competitive market situations. The result of this study shows that the number, market share, and the age of both brand-name and generic products have the most explanatory power for explaining the price premium. This study further applies this method to a pharmaceutical price index in order to explain 'Drug Price Index Perplexities.'

Document Type: Research Article

DOI: http://dx.doi.org/10.1080/0003684042000222106

Affiliations: School of Business and Economics University College of the Cariboo Kamloops British Columbia Canada V2C 5N3, Email: ykong@cariboo.bc.ca

Publication date: April 1, 2004

More about this publication?
routledg/raef/2004/00000036/00000007/art00008
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more